MANNKIND CORP — Director's Dealing 2022

May 26, 2022

SEC Form 4/A — Form 4/A

Issuer: MANNKIND CORP (MNKD)
CIK: 0000899460
Period of Report: 2022-05-18

Reporting Person: Galindo Alejandro (EVP Endocrine Business Unit)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-18	Common Stock, $.01 Par Value	I	4789	$3.19	Acquired	776690	Direct

Footnotes

F1: This report corrects total amount of securities beneficially owned as no shares were withheld to satisfy the tax liability incident on 5/18/2022 for the vesting of previously reported restricted stock units.